GRC 54276

GRC-54276 · Glenmark Specialty S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GRC 54276, covering 2024-07-22 to 2024-07-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas. [Phase 1]